A Case of the Cons: How Contraception Confused Congenital Adrenal Hyperplasia for Conn
October 2020
in “
Journal of the American Society of Nephrology
”
New to Hydrocortisone? There is a guide in the encyclopedia. Read the guide → Studysummary In this case study, drospirenone use masked the diagnosis of a rare form of congenital adrenal hyperplasia, suggesting a possible delay in detecting underlying endocrinopathies. Our plain-language summary of this paper — not a Tressless recommendation.
This case study described a 21-year-old female initially misdiagnosed with polycystic ovarian syndrome (PCOS) and treated with drospirenone-ethinyl estradiol, which masked symptoms of congenital adrenal hyperplasia (CAH) due to 11-beta hydroxylase deficiency (11BHD). The patient presented with hypokalemic alkalosis, hypertension, and hirsutism. After discontinuing the oral contraceptive, further investigation revealed elevated ACTH, DHEA-S, 11-deoxycortisone, and testosterone levels, leading to a diagnosis of non-classical CAH. Treatment with hydrocortisone normalized her blood pressure and electrolyte levels. The study highlighted the potential for drospirenone to obscure underlying endocrinopathies and suggested the need for clinical trials to evaluate its role in treating such conditions.
